MarketsGlobal Healthcare10 July 2026
Inside Vertex's $10 Billion Bet on Crinetics
Vertex's $10 billion acquisition of Crinetics is about far more than adding another drug to its portfolio. It is a strategic bet on an endocrinology platform that could fuel the company's next phase of growth.
Vertex PharmaceuticalsCrinetics PharmaceuticalsBiotechnologyMergers and Acquisitions
Abdul Wasey Bhatti6 min read
Read Article